Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 7Terminated 4Unknown 3Withdrawn 1Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 2Thoracic 1Plasma cell 1Other hematologic neoplasm 1Other 1Myeloid 1Gynecologic 1Gastrointestinal 1Dermatologic 1Breast 1

Conditions

Ovarian Neoplasms 109Uterine Cervical Neoplasms 57Endometrial Neoplasms 38Fallopian Tube Neoplasms 34Carcinoma, Ovarian Epithelial 27Breast Neoplasms 25Neoplasms 15Carcinoma, Non-Small-Cell Lung 13Pancreatic Neoplasms 12Uterine Cervical Dysplasia 11Recurrence 11Stomach Neoplasms 10Neoplasm Metastasis 10Lung Neoplasms 9Colorectal Neoplasms 9Uterine Neoplasms 8Triple Negative Breast Neoplasms 8Sarcoma 8Urinary Bladder Neoplasms 7Melanoma 6Esophageal Neoplasms 6Vulvar Neoplasms 5Vaginal Neoplasms 5Testicular Neoplasms 5Lymphoma, Non-Hodgkin 5Small Cell Lung Carcinoma 4Sezary Syndrome 4Rectal Neoplasms 4Prostatic Neoplasms 4Precursor Cell Lymphoblastic Leukemia-Lymphoma 4

Interventions

Aprepitant 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Withdrawn × Nausea × Gynecologic × Clear all
NCT01017809 2015-03-18

Prolonged Emend in a Study (NYU 03-67) of Oxaliplatin and Topotecan in Previously Treated Ovarian Cancer

NYU Langone Health

Phase NA Withdrawn
Gynecologic

Nausea, Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡